Abstract -A brief history of bedside testing is presented. Anaytes which can readily be studied at the bedside are identified and the instruments which may be used are briefly described. The advantages and limitations of bedside measurements are discussed. An attempt is made to anticipate the future potencialities and challenges of this aspect of clinical laboratory science.
INTRODUCTION
Clinical laboratory practice has had an explosive growth within the past two decades. One of the trends that has evolved within this dramatic expansion is the evolution of instruments which can be used at the bedside. As with any other change in health delivery practice, one finds ardent supporters of the trend and others who speak in a negative manner or with great reservation. Bedside situations range from an intensive care unit in an American hospital to a primitive bedside in a dwelling in the rural part of India.
I will consider all types and will not confine my attention to sophisticated hospitals nor only to rural bedsides in developing countries. The objective in all situations involves obtaining information.
HISTORICAL BACKGROUND OF BEDSIDE TESTING
Hospitals have not always had clinical laboratories. In fact it is only within the past 50 years that a clinical laboratory has been regarded as a critical component of a hospital. Prior to the time laboratories were part of hospitals, there was actually very little laboratory study of any sort. However much of the testing that was done occurred at the bedside. Hydrometers were used to measure the specific gravity of urine. Several well designed instruments were created for measuring hemoglobin concentration of blood. The HadenHauser Hemoglobinometer' is an example of such an instrument which was designed and used quite widely in the USA about 50 years ago. The microscope is an instrument or device which received significant attention for bedside testing. This is emphasized by the fact that many paintings depicting the diagnosis and treatment of disease in the 19th century had a group of individuals at the bedside with one of them intently using a microscope. The tests that were done at the bedside involved the recognition of bacteria in urine, identification of casts nd cells in the urine, recognition of bacteria in spinal fluid, and evaluation of the number and characteristics of the erythrocytes and the leucocytes in the blood.
The very first clinical chemistry laboratory in the USA was initiated at the New York Postgraduate Hospital during the second decade of the present century. Victor C. Myers, with a recent Ph.D. in Biochemistry from Yale University, was in charge of the laboratory.
I have had an opportunity to hear first hand about this laboratory since I was later a graduate student of Dr. Myers. Blood sugar, urea, creatinine, chloride and uric acid were the principal measurements made in this early laboratory. However, the initiation of hospital laboratories tended to discourage bedside testing.
I had an opportunity to work for a Clinical Laboratory for one summer slightly less than 50 years ago. This laboratory which was part of a large university medicel school served a medical center with approximately 600 beds and a large outpatient population. DuBosc type colorimeters were used since at that time there were no spectrophotometers or "photoelectric colorimeters". There was a Van Slyke instrument for measuring C02 capacity. There were no pH meters or glass electrodes, no flame photometers, no chromatography or electrophoresis. Amylase and alkaline phosphatase were the only enzymes measured. Three other persons and myself did all of the analyses and also washed all of the glassware. There was no stat service and no night service. The laboratory functioned for 5-1/2 days per week, but on Sunday the lab was closed. At that time there was essentially no bedside testing that I was aware of.
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During the period between 1920 and 1950 there was a continuing growth of clinical laboratories, but the interest and usage of bedside tests declined. The feeling prevailed that the clinical laboratory could create all of the information required for correct diagnosis and good patient care.
Within the past two decades there has been a great increase in all types of clinical laboratory instrumentation. Within this complex array, there has appeared a small component of instruments and systems which are specifically designed or are adaptable to bedside testing.
ANALYTES, INSTRUMENTS AND INFORMATION -CURRENT STATUS
Within the past decade there has been a literal explosion of procedures and instrument technology relating to the clinical laboratory. This same dramatic change has not occurred with regard to the number of analytes which are widely studied although the number is growing. Instrumentation and automation which has been designed to function at the bedside or is applicable to bedside application is a small but interesting component of the explosive growth of clinical laboratory technology.
I propose to describe the current status of bedside testing involving automation and instrumentation. It is not practical to review every procedure and every instrument but examples of many will be mentioned. The basis for paragraph separation is primarily with respect to analytes but this is not practical in all cases. Methods are identified with regard to the type of specimen by indications of WB for whole blood, S for serum, P for plasma, TC for transcutaneous, B for breath, U for urine and T for tissue. The various components of bedside laboratory study include clinical chemistry, toxicology, hematology, microbiology and immunology.
Blood Volume (WB) Blood volume may redily be measured at the bedside by the intravenous injection of a measured quantity of lt5I labelled human serum albumin. After a few minutes to allow for mixing, a specimen of blood is removed and the amount of dilution of the isotopically labelled albumin measured. This measurement is made rapid, convenient and accurate by the use of a programmed instrument which automatically counts the radioactivity of the albumin prior to injection and of the blood following dilution in the circulating system. From these values the instrument gives a direct readout in terms of liters of blood volume. One example of such an instrument is the Volemetron®. Blood volume measurements are useful in cases of severe burns.
Serum Ketone (S/P) Ketone bodies occur in the serum in readily measurable amounts in diabetic ketoacidosis. The changes in serum ketone levels have been used as a bedside monitoring test in the treatment of diabetic coma. One easy-to-use method for measuring serum ketone is to moisten the reagent area of a Ketostix® with a small quantity of serum and then read the color 15 seconds later. Values are obtained by comparison with a color chart. Alternatively the ketone area of Multistix® or N-Multistix® can be used and the reading made with the instrument, Clini-Tek® Glucose (WB) Distortions in blood sugar which occur in diabetes may involve either elevations above the normal range (hyperglycemia) or decreases below the normal range (hypoglycemia). Measurement of blood sugar on small specimens of whole blood obtained by skin puncture is a bedside test. One system for such measurement is Dextrostix®/Glucometer®. This involves a reagent strip on to which a large drop of blood is placed. After exactly one minute, the blood is washed off and the strip is inserted into a small reflectance measuring instrument. A direct reading of the color is translated into a value for blood sugar which appears on the lighted panel of the instrument in digital readout form. Fig. 1 is a photograph of a Gl ucometer.
Hemoglobin (WB)
Measurements of the hemoglobin content of blood at the bedside originated several centuries ago when physicians looked at a specimen of blood from a patient and decided from the color of the blood that the blood was too thick or too thin. These judgements of color were indications of the amount of hemoglobin. Subsequently, instruments based on visual color comparisons appeared and these were to a significant degree used at the bedside. It was not until the appearance of clinical laboratories in hospitals that hemoglobin measurement at the bedside diminished due to the measurements being moved to the clinical laboratory. Quite recently easy-to-use instruments have reappeared at the bedside. These include sophisticated instruments such as the Hemoximeter® which automatically measures and displays the result for hemoglobin as well as the oxygen saturation of the hemoglobin. Relatively small portable compact, battery-operated colorimetric instruments specifically provided with unitized reagents are also available. test is used for identification of hemophilia A and von Willebrand's disease which are the most frequent congenital coagulation defects. The measurement of activated partial thromboplastin time (APTT) can be used for the control of heparin therapy and responds to decreases in Factor VIII, IX, XI and XII. Automated coagulation apparatus can be used which involves an optical endpoint determination. Cephotest (Nyegaard) is an example of a reagent system for this measurement.
Activated Recalcification Time (WB) Activated recalcification time is a useful monitor of the in vivo anticoagulation status of patients being treated with certain anticoagulants such as heparin. Blood is drawn into a pretreated tube which is then inserted into a heated rotary mechanism which automatically signals the time of test completion. An example of the instrument used to carry out this measurement is the Hemachron®.
Endogenous Platelet Aggregation (WB)
The platelet aggregation of blood can be evaluated endogenously by means of an instrument which circulates blood through special filters. Aggregation of platelets causes measurable pressure changes within the system. These pressure changes are directly related to platelet aggregation. An example of such an instrument is the Filtragometer®.
Urine Studies Urine provides a wide variety of information which is useful in very many situations. The evolution of automated chemical reaction systems for the major constituents of urine makes it practical to study urine at the bedside without the use of automated instruments. Table 1 lists the chemical tests which may provide bedside information and also identifies the key information which can be of importance at the bedside. There is other information which may be important at the bedside but the objective of the table is not to provide a comprehensive tabulation of all of the possibilities. Some of this information is important in the primary diagnosis or monitoring of treatment. Other information may be useful in identifying secondary complications. Additionally other information may be pertinent in helping to rule out complications. For instance a urine pH of 6 or 7 minimizes the likelihood of acidosis. A urine specific gravity of 1.030 provides information that dehydration may be present whereas a urine pH of 1.015 makes dehydration most unlikely. Automated ready-to-react chemical systems are available for each of the 10 constituents listed in Table 1 .
Each reagent system when moistened with urine generates a color which indicates the presence or absence of the constitutent and if present the approximate amount. Visual measurements involve comparison with standardized color charts at specific times following the dipping of the reagent in the urine specimen. An automated instrument is available for reading the reacted colors of the first 8 constituents listed in Table 1 . A multiple reagent strip such as N-Multistix® is dipped in the urine specimen and then placed on the tray of the instrument which following activation makes a reflectance reading of the color of each reacted area. Results are then displayed on a lighted panel or also can be processed through a printer or entered directly into a computer. An example of an automated instrument for reflectance reading of reacted dip-and-read urine strips is Clini-Tek®. Fig. 8 is a photograph of Clini-Tek. Frozen Sections (T) Bedside oy patient proximity measurements have an important utility with relation to examination of biopsy tissue for evidence of malignancy. A typical situation is the surgical examination of a deep organ or body area in the surgical amphitheatre. The surgeon makes a biopsy of the organ or suspected tissue, and gives the tissue to the pathologist or technologist who promptly freezes the tissue in a block of dry ice and then makes frozen sections for micrbscopic examination. Meanwhile the surgeon awaits the verdict of the pathologist examining the sections as to whether or not malignancy is evident as a basis for the course of further surgical intervention. The preparation of the frozen sections is carried out with an instrument called a microtome-cryostat. This is a mobile electropowered instrument which has 
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changing therapy altogether. Bedside testing can produce closer interrelationship between patient and laboratorian--especially in instances when laboratory personnel become involved with performing bedside tests as a routine--it makes the laboratorian more a part of the team. Sometimes a complaint is heard from the laboratory that the clinicians do not give sufficient attention to laboratory results. It is likely that in some cases such complaints are invalid, but in some instances they are valid. Bedside testing, particularly when the physician is present is likely to create an enhanced awareness and utilization of laboratory information. Another advantage of bedside testing is that the instrumentation and technology used at the bedside may have other important applications or may lead to other applications. For instance, technology used in the Biostator which automatically measures blood sugar through continual sampling through a cannula and injects glucose or insulin as the hospitalized patient requires based on the blood glucose result, has proceeded through mniaturization steps and may soon be applied to new devices which perform the same function but are small enough for diabetics to carry on their person. It is difficult to measure costeffectiveness over such a wide variety of instrumentations and methods used at the bedside. Some methods are obviously cost-effective if they decrease patient hospitalization days. Others may or may not be cost-effective depending on the comparisons made and the viewpoint of the evaluator.
As with any kind of laboratory testing, bedside testing also has limitations. There may be errors due to poorly trained personnel. Some of the bedside methods appear so easy and simple that there might be a tendency for poorly trained persons to use them without regard for specific necessary knowledge required for proper usage. In this same type of situation there is likely to be a lack of concern about effective quality control programs, and the use of controls could be inadequate for best results. It is also possible that with infrequent use, or with misuse, instrumentation may malfunction. Such malfunctions may occur in subtle ways so that untrained personnel are not aware of the difficulties. Also malfunction may arise from improper maintenance or lack of it altogether. On the other hand, bedside instrumentation such as intensive care monitoring units are subjected to the closest scrutiny and the best possible control and maintenance. Extra costs are another possible limitation to bedside methods. Required capital investment obviously will contribute to higher costs if the instrumentation is at all expensive. Actual cost per test may be significantly higher for bedside tests but in many other examples may be significantly lower when compared to regular routine laboratory tests and overhead expense. The limitations suggested can be avoided if there is adequate training, supervision and effective use of control and maintenance.
FORECASTING THE FUTURE
The future of bedside testing provides an intriguing topic which can encompass a wide variety of attitudes and opinions. The total field of clinical laboratory science is a rapidly growing one and has experienced impressive changes within the past two decades. These changes have evolved primarily because of the realization of the important contribution of clinical laboratory information to health delivery. There is no current basis for a prediction that clinical laboratory science will not continue to flourish and make an even greater contribution within the next two decades. Correspondingly it is realistic to envision that bedside testing will play an increasingly important part in the overall growth of clinical laboratory science and automation. Table 2 identifies some of the influences which will have an impact on the future of bedside study. These and possibly other factors will influence There are several areas of bedside clinical laboratory study which are likely to receive special attention and special benefits. Computers and electronic data banks have the potentiality of making dramatic contributions. Miniaturization of instruments and data handling devices is a trend that will gain momentum. Microbiology, hematology and immunology will profit by increasing research and technology and should become much more important in bedside study. Finally the potentialities of the professional laboratory scientist will be expanded by the bedside component of the whole field. Health delivery has improved the quality of life and will continue to do so in the future even though the manner in which it functions is an ever-changing one.
